All material is intended solely for educational and informational purposes.
Fenbendazole and Ivermectin: A Practical Daily Protocol Guide
Fenbendazole and ivermectin are the two most discussed antiparasitic compounds in cancer repurposing research. You have read the research. You understand the mechanisms. Now you need to know what to actually do: what to take, when, with what, how to cycle it, and what to watch for.
This guide is structured in two parts. The first covers the cancer-adjunct approach, meaning use alongside conventional oncology treatment. The second covers the antiparasitic and preventive approach used by people not in active cancer treatment. The compounds are the same; the doses, schedules, and monitoring needs differ significantly between the two contexts.
For the mechanistic background on why these two compounds are used together, see The Dr. William Makis Fenbendazole Protocol. For the full breakdown of ivermectin's off-label dosing research, see The Low-Dose Ivermectin Protocol: What the Off-Label Community Is Actually Doing.
Form: 0.5% lotion
Approval: FDA-approved in 2012, available over the counter since 2023
Regardless of which protocol section applies to you, two things are true for every person using either compound.
Both require fat to absorb properly. Fenbendazole has poor water solubility, without dietary fat, only a fraction enters circulation. Ivermectin's absorption is approximately 2.5 times higher with a high-fat meal than in the fasted state. A tablespoon of olive oil, full-fat yogurt, eggs, avocado, or any fat-containing meal taken at the same time as your dose is not optional. It determines whether the drug reaches relevant concentrations.
Both are processed through the liver. Baseline liver function testing before starting is strongly advisable. Ongoing monitoring matters for extended use. This is covered in detail at the end of each section.
Before You Start: Two Non-Negotiables
Part One: Cancer-Adjunct Protocol
This section is for people using fenbendazole and ivermectin alongside conventional cancer treatment, or as part of an integrative oncology approach. The dosing here is based on the 2024 peer-reviewed protocol by Baghli, Martinez, Makis, and Marik, published in the Journal of Orthomolecular Medicine.
This protocol should be discussed with your oncologist before starting. Both compounds interact with liver metabolic pathways shared by many chemotherapy agents. Disclosure is not optional.
Fenbendazole Dosing
Start at 222 mg and assess tolerance over the first two weeks before considering any increase. Take with a fat-containing meal, morning or midday preferred.
⚠️ For convenience only. Consult a licensed professional.
Ivermectin Dosing
Ivermectin in this protocol is weight-based. Calculate your dose using your actual current body weight.
Example for a 70 kg person:
Low-grade: 21 mg/day
Intermediate: 35 mg/day
High-grade: up to 70 mg/day
These doses are significantly above the approved single-dose range for parasitic infections. High-grade dosing in particular requires physician involvement. Do not estimate body weight, weigh yourself and calculate precisely.
Can They Be Taken Together?
Yes. Both can be taken at the same meal. Taking them together with a fat-containing meal is the most practical approach and ensures both compounds get the fat co-administration they need. There is no known pharmacological reason to separate them.
If you are deciding between a combined capsule and separate products, the key variable is whether the fixed ivermectin dose in the combo matches your weight-based target. For most people above 80 kg, a standard combo capsule will underdose the ivermectin component. For a full comparison see Fenbendazole and Ivermectin: 2-in-1 Combo or Separate Bottles?.
Adjunct Supplements
These are the components from the published 2024 protocol:
The full scientific rationale for each addition is covered in The Fenbendazole Supplement Stack.
Binders: Supporting Detox During the Protocol
As fenbendazole and ivermectin work, dying cancer cells and any parasites present release toxins into the body. Binders are compounds that attach to these waste products in the digestive tract before they can be reabsorbed, helping the body clear them more efficiently.
Commonly used binders in this context:
Critical timing rule: binders must be taken at least 2 hours before or after fenbendazole and ivermectin. Taken too close together, they will bind the drugs themselves and significantly reduce absorption. Morning dosing of fenbendazole and ivermectin with breakfast, binders taken at bedtime, is the simplest way to maintain safe separation.
Binders are taken at bedtime rather than with meals to maintain the required 2-hour separation from fenbendazole and ivermectin. Taking them too close together reduces absorption of both compounds.
What a Typical Day Looks Like
Morning (with fat-containing breakfast): Fenbendazole + ivermectin + vitamin D3 + curcumin + quercetin
Before lunch: Berberine (first dose)
Before dinner: Berberine (second or third dose)
Before bed (minimum 2 hours after fenbendazole / ivermectin): Binder — activated charcoal or chosen alternative
On fenbendazole rest days (day 4 in the 3-on/4-off cycle), continue ivermectin and all adjuncts as normal. On the ivermectin rest day (day 7 in the 6-on/1-off cycle), continue fenbendazole if it falls on an active day. Binders can be taken every day regardless of which compounds are active.
Monitoring: Cancer-Adjunct Context
Before starting:
Full liver function panel (ALT, AST, ALP, bilirubin)
Kidney function (creatinine, eGFR)
Full blood count
Every 4 weeks:
ALT, AST minimum.
Any upward trend warrants dose reduction before the next scheduled test.
Stop immediately and contact your physician if: jaundice, dark urine, severe fatigue, nausea that does not resolve, or any significant change in how you feel.
Part Two: Antiparasitic and Preventive Protocol
This section is for people using fenbendazole and ivermectin for general antiparasitic purposes, broad-spectrum deworming, or as a low-dose preventive stack.
For background on what parasites fenbendazole actually treats and its original veterinary use case, see Fenbendazole and Parasites: The Original Use Case.
Fenbendazole Dosing
Take with a fat-containing meal. A single three-day course is standard for most intestinal parasite clearance. Ongoing preventive use follows the 3-on/4-off weekly cycle.
Example for a 70 kg person:
Standard antiparasitic dose: 10.5–14 mg
Low-dose preventive: 7–14 mg per session
Take with a fat-containing meal.
Ivermectin Dosing
Adjunct Supplements (Optional in This Context)
Binders: Essential During Antiparasitic Clearance
Binders are particularly important in the antiparasitic context.
When parasites die in large numbers during a clearance course, they release waste products and endotoxins that the body needs to eliminate quickly.
Without binders, these byproducts can be partially reabsorbed in the gut, contributing to what some people describe as a die-off reaction: temporary fatigue, headache, or digestive discomfort in the days after starting a protocol.
Commonly used binders:
The same 2-hour separation rule applies here. Take binders at a different meal from fenbendazole and ivermectin. Bedtime is the most practical timing if the antiparasitic compounds are taken with breakfast or lunch. Stay well hydrated on days you use binders, particularly bentonite clay or charcoal, to support their effectiveness and prevent constipation.
What a Typical Day Looks Like
Morning (with fat-containing breakfast): Fenbendazole + ivermectin
With meals (optional): Vitamin D3 + curcumin
Before bed (minimum 2 hours after fenbendazole / ivermectin): Binder — activated charcoal or chosen alternative
Monitoring: Preventive Context
Before a first course: Basic liver function check if you have no recent bloodwork. Not mandatory for a single short course in a healthy adult, but advisable before starting ongoing use.
For ongoing weekly use: Liver function check every 8–12 weeks.
Watch for: Persistent fatigue, changes in digestion, or any yellowing of skin or eyes. These are signals to pause and test.
Common Mistakes Worth Avoiding
Taking without fat. The most common and most consequential mistake. If absorption is low, the protocol is not working regardless of what dose you take.
Taking binders too close to the compounds. Less than 2 hours of separation means the binder may bind the drug rather than the toxins. Bedtime dosing of binders is the simplest solution.
Skipping rest days. Both compounds are liver-metabolized. Continuous daily use without rest days increases cumulative hepatic load over time.
Not monitoring liver function. Elevated liver enzymes are the earliest signal of a problem. Without bloodwork, you have no early warning system.
Using veterinary formulations. Veterinary ivermectin products are formulated at concentrations many times higher than human tablets. They are not equivalent and introduce serious overdose risk. Only pharmaceutical-grade human products should be used.
Treating the protocol as a replacement for oncology care. In the cancer-adjunct context, these compounds are proposed as additions to conventional treatment, not substitutions for it.
Key Takeaways
Fat co-administration is non-negotiable for both compounds. Without it, absorption is insufficient for either protocol to function as intended.
Binders must be taken at least 2 hours apart from fenbendazole and ivermectin. Bedtime is the most practical timing.
Cancer-adjunct dosing is weight-based for ivermectin and significantly higher than preventive doses. High-grade cancer dosing requires physician involvement.
The two compounds can be taken together at the same fat-containing meal. There is no pharmacological reason to separate them.
Cycling schedules matter because both compounds are hepatically metabolized. Rest days reduce cumulative liver load.
Liver function monitoring every 4 weeks in the cancer-adjunct context; every 8–12 weeks in the preventive context.
Only pharmaceutical-grade human products should be used. Veterinary formulations carry serious overdose risk.
⚠️ For convenience only. Consult a licensed professional.
Frequently Asked Questions
Can I take fenbendazole and ivermectin on the same day?
Yes. Both can and should be taken together with a fat-containing meal. There is no known interaction that makes simultaneous administration a problem. Taking them together is the most practical approach and ensures both receive the fat co-administration needed for adequate absorption.
When exactly should I take binders?
At least 2 hours before or after your fenbendazole and ivermectin dose. The simplest approach: take the antiparasitic compounds with breakfast, take binders at bedtime. This guarantees safe separation without requiring careful timing throughout the day.
What fat should I take them with?
Any fat-containing food works: olive oil, eggs, avocado, full-fat yogurt, butter, nuts. A tablespoon of olive oil taken at the same time as the capsules is the most commonly used approach. The amount of fat does not need to be large; it needs to be present.
How do I calculate my ivermectin dose?
Weigh yourself in kilograms. Multiply your weight by the target mg/kg for your situation: 0.2 mg/kg for antiparasitic use, 0.3–1 mg/kg for cancer-adjunct use depending on grade. Use pharmaceutical-grade tablets and calculate precisely.
What if my fenbendazole and ivermectin rest days fall on different days?
This is normal given the different cycling schedules. On a fenbendazole rest day, continue ivermectin as scheduled and vice versa. The rest days are compound-specific; they do not need to coincide. Binders can be taken every day regardless of which compounds are active.
How long should I stay on this protocol?
There is no clinically validated duration for either context. In the cancer-adjunct community, 12-week cycles with reassessment are common. In the preventive context, ongoing use with the 3-on/4-off weekly cycle is typical. Liver function monitoring at regular intervals is the primary ongoing safety check regardless of duration.
All material is intended solely for educational and informational purposes.
References
Baghli I, Martinez P, Makis W, et al. Targeting the mitochondrial-stem cell connection in cancer treatment: a hybrid orthomolecular protocol. J Orthomolecular Med. 2024;39(3). Published September 19, 2024.
Nguyen J, Nguyen TQ, Han B, Hoang BX. Oral fenbendazole for cancer therapy in humans and animals. Anticancer Res. 2024;44(9):3725–3735.
Yuan J, Walker M, Lin D, et al. A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer. J Clin Oncol. 2025;43(16 suppl):e13146.
Juarez M, Schcolnik-Cabrera A, Dueñas-González A. The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res. 2018;8(2):317–331.
Dogra N, Kumar A, Bhardwaj T. Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. Drug Des Devel Ther. 2020;14:3839–3850.
Drugs.com. Ivermectin dosage guide. 2026. https://www.drugs.com/dosage/ivermectin.html